Abstract:Aims/Purpose: Over the past decades, polymeric particles have become widespread in the field of drug delivery. Silica microparticles (SiMPs) are biodegradable—silicic acid being the main degradation product—and can release medication sustainably for a long period of time. Our aim was to determine the effects of soluble silicic acid on in vitro models of human epithelial cells. Methods: HCE‐2 and ARPE‐19 cells were exposed to serial dilutions of silicic acid produced by dissolving silica hydrogel in PBS, and cell viability was assessed after 24, 48 and 72 h of incubation. Cell viability data were provided by AlamarBlue assay, while membrane integrity was analysed through LDH release. For more information on the silicic acid impact on cellular stress, we assayed biochemical markers, such as IL‐6, IL‐8, MCP‐1, Caspase‐3 and Hsp‐70, using specific ELISAs. Results: AlamarBlue assay did not show any statistical differences in survival rate between the control group and maximum 30 μg/mL silicic acid in all timepoints in ARPE‐19 cells (24 h 95.42 ± 4.81%, 48 h 87.55 ± 6.48% and 72 h 97.64 ± 6.38%) and HCE‐2 cells (24 h 97.38 ± 5.97%, 48 h 100.81 ± 8.32% and 72 h 101.73 ± 2.62%). Additionally, we did not detect any toxic changes in LDH release test in ARPE‐19 cells in 24, 48 and 72 h time points (30 μg/mL silicic acid: 24 h 9.0 ± 11.5%, 48 h 10.4 ± 13.4% and 72 h 13.8 ± 16.6%). The LDH release data in treated (max. 30 μg/mL) HCE‐2 cells were comparable to control cells. Assessed inflammatory markers mostly were similar as well when comparing control and treatment groups, although IL‐6, MCP‐1, Caspase‐3 and Hsp‐70 showed increased values with time. Conclusions: Our results do not show major cytotoxicity of silicic acid on the two different epithelial cell lines, nor did not induce stress or inflammatory markers. Therefore, these findings support the use of our novel SiMPs as drug delivery vehicles in the treatment of ophthalmic diseases.

In Vitro Release and Irritation of Ocular Sirolimus Chitosan-coated Liposomal In-situ Gels

Preparation and in vivo and ex vivo studies of sirolimus nano-in-situ gel ophthalmic formulation

Preparation and Sustained Release Properties of Sirolimus-Loaded Microspheres for Subconjunctival Injection in Vitro

In situ forming hydrogels based on modified gellan gum/chitosan for ocular drug delivery of timolol maleate

Chitosan-based Thermosensitive Hydrogel As a Promising Ocular Drug Delivery System: Preparation, Characterization, and in Vivo Evaluation.

The Effect of Fluid Shear Stress on the In Vitro Release Kinetics of Sirolimus from PLGA Films

Chitosan/carbomer nanoparticles- laden in situ gel for improved ocular delivery of timolol: in vitro, in vivo, and ex vivo study

Ocular Delivery of Cyclosporine A Based on Glyceryl Monooleate/poloxamer 407 Liquid Crystalline Nanoparticles: Preparation, Characterization,in Vitrocorneal Penetration and Ocular Irritation

Comparative study of cyclosporine A liposomes and emulsions for ophthalmic drug delivery: Process optimization through response surface methodology (RSM) and biocompatibility evaluation

Observation of Cyclosporin A: Sustained Release Intraocular Lens Implantation in Rabbit Eyes

Preparation and Evaluation of Ophthalmic Ph Sensitive In-Situ Gel of Acyclovir

Simultaneous interpenetrating silicone hydrogel based on radical/addition polymerization for extended release of ocular therapeutics

Study of in vitro dissolution and drug release for ibuprofen in-situ gel

Fabrication and characterization of silk fibroin-coated liposomes for ocular drug delivery

Development of ion-triggered in situ gel containing ketoconazole/hydroxypropyl-β-cyclodextrin for ocular delivery: in vitro and in vivo evaluation

Preparation of a thermosensitive and antibacterial in situ gel using poloxamer-quaternized chitosan for sustained ocular delivery of Levofloxacin hydrochloride

Efficacy, safety, and biodegradation of a degradable scleral buckle of chitosan-gelatin polymer in rabbits.

Tolerability of silica microparticle gels as drug delivery vehicles

In situ formation of injectable organogels for punctal occlusion and sustained release of therapeutics: design, preparation, in vitro and in vivo evaluation

Hydrogel Containing Silica Shell Cross-Linked Micelles for Ocular Drug Delivery

In Situ Formation of Injectable Gelatin Methacryloyl (GelMA) Hydrogels for Effective Intraocular Delivery of Triamcinolone Acetonide